Arcadia Biosciences Statistics
Total Valuation
RKDA has a market cap or net worth of $2.20 million. The enterprise value is -$2.36 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RKDA has 2.06 million shares outstanding. The number of shares has increased by 0.35% in one year.
| Current Share Class | 2.06M |
| Shares Outstanding | 2.06M |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 1.90% |
| Float | 2.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| Forward PS | 0.28 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.09
| Current Ratio | 3.09 |
| Quick Ratio | 2.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -45.14% and return on invested capital (ROIC) is -62.39%.
| Return on Equity (ROE) | -45.14% |
| Return on Assets (ROA) | -32.71% |
| Return on Invested Capital (ROIC) | -62.39% |
| Return on Capital Employed (ROCE) | -117.00% |
| Weighted Average Cost of Capital (WACC) | 8.21% |
| Revenue Per Employee | $607,250 |
| Profits Per Employee | -$292,375 |
| Employee Count | 8 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, RKDA has paid $8,000 in taxes.
| Income Tax | 8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.03% in the last 52 weeks. The beta is 0.72, so RKDA's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -69.03% |
| 50-Day Moving Average | 1.57 |
| 200-Day Moving Average | 3.02 |
| Relative Strength Index (RSI) | 27.90 |
| Average Volume (20 Days) | 26,202 |
Short Selling Information
The latest short interest is 1,595, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 1,595 |
| Short Previous Month | 927 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.08% |
| Short Ratio (days to cover) | 0.07 |
Income Statement
In the last 12 months, RKDA had revenue of $4.86 million and -$2.34 million in losses. Loss per share was -$1.71.
| Revenue | 4.86M |
| Gross Profit | 1.75M |
| Operating Income | -5.25M |
| Pretax Income | -2.33M |
| Net Income | -2.34M |
| EBITDA | -5.22M |
| EBIT | -5.25M |
| Loss Per Share | -$1.71 |
Full Income Statement Balance Sheet
The company has $4.56 million in cash and n/a in debt, giving a net cash position of $4.56 million or $2.22 per share.
| Cash & Cash Equivalents | 4.56M |
| Total Debt | n/a |
| Net Cash | 4.56M |
| Net Cash Per Share | $2.22 |
| Equity (Book Value) | 4.14M |
| Book Value Per Share | 3.02 |
| Working Capital | 4.30M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -4.74M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 32,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -4.74M |
| FCF Per Share | -$2.30 |
Full Cash Flow Statement Margins
Gross margin is 36.04%, with operating and profit margins of -108.07% and -48.15%.
| Gross Margin | 36.04% |
| Operating Margin | -108.07% |
| Pretax Margin | -47.98% |
| Profit Margin | -48.15% |
| EBITDA Margin | -107.41% |
| EBIT Margin | -108.07% |
| FCF Margin | n/a |